The bilirubin content in the vitreous body of the eye of human fetuses of gestation week 17-31 was measured. During gestation weeks 17-19, the mean bilirubin concentration was 8.67 μmol/liter; then, decreased to 1.37 μmol/liter (gestation weeks 20 to 31). Bilirubin, being an endogenous antioxidant, is probably involved in protection of the retina and lens from LPO processes that intensively develop in retinal neurons and lens fibers.
Similar content being viewed by others
References
Doré S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, Snyder SH. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl Acad. Sci. USA. 1999;96(5):2445-2450.
Kurzel RB, Heinrikson RL. On the presence of bilirubin in the ocular humors of premature infants. Invest. Ophthalmol. 1976;15(6):509-512.
Le Goff MM, Bishop PN. Adult vitreous structure and postnatal changes. Eye (Lond). 2008;22(10):1214-1222. https://doi.org/10.1038/eye.2008.21
Liu Y, Li P, Lu J, Xiong W, Oger J, Tetzlaff W, Cynader M. Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 2008;181(3):1887-1897.
Lovicu FJ, McAvoy JW. Growth factor regulation of lens development. Dev. Biol. 2005;280(1):1-14.
Naumann HN, Young JM. Comparative bilirubin levels in vitreous body, synovial fluid, cerebrospinal fluid and serum after death. Proc. Soc. Exp. Biol. Med. 1960;105:70-72.
Panova IG, Tatikolov AS. Investigation of the content of alpha-fetoprotein and serum albumin in the vitreous body of the eye of human embryos. Biol. Bull. 2011;38(2):191-194. https://doi.org/10.1134/S1062359011020105
Panova IG, Yakovleva MA, Tatikolov AS, Kononikhin AS, Feldman TB, Poltavtseva RA, Nikolaev EN, Sukhikh GT, Ostrovsky MA. Lutein and its oxidized forms in eye structures throughout prenatal human development. Exp. Eye Res. 2017;160:31-37. https://doi.org/10.1016/j.exer.2017.04.008
Provis JM, Penfold PL, Cornish EE, Sandercoe TM, Madigan MC. Anatomy and development of the macula: specialisation and the vulnerability to macular degeneration. Clin. Exp. Optom. 2005;88(5):269-281.
Sedlak TW, Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics. 2004;113(6):1776-1782.
Usman F, Diala UM, Shapiro SM, Le Pichon JB, Slusher TM. Acute bilirubin encephalopathy and its progression to kernicterus: current perspectives. Res. Reports Neonatology. 2018;8:33-44. https://doi.org/10.2147/RRN.S125758
Vítek L, Ostrow JD. Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects. Curr. Pharm. Des. 2009;15(25):2869-2883. https://doi.org/10.2174/138161209789058237
Weiner CP. Human fetal bilirubin levels and fetal hemolytic disease. Am. J. Obstet. Gynecol. 1992;166(5):1449-1454.
Yee KM, Feener EP, Madigan M, Jackson NJ, Gao BB, Ross-Cisneros FN, Provis J, Aiello LP, Sadun AA, Sebag J. Proteomic Analysis of Embryonic and Young Human Vitreous. Invest. Ophthalmol. Vis. Sci. 2015;56(12):7036-7042. https://doi.org/10.1167/iovs.15-16809
Zhu M, Madigan MC, van Driel D, Maslim J, Billson FA, Provis JM, Penfold PL. The human hyaloid system: cell death and vascular regression. Exp. Eye Res. 2000;70(6):767-776.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 170, No. 7, pp. 118-120, July, 2020
Rights and permissions
About this article
Cite this article
Panova, I.G., Sukhova, Y.V., Tatikolov, A.S. et al. Bilirubin in the Vitreous Body of the Eye of Human Fetuses. Bull Exp Biol Med 170, 98–100 (2020). https://doi.org/10.1007/s10517-020-05012-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-020-05012-3